New digital health firms join Stockholm life science hotlist

Published March 2016 in collaboration between Invest Stockholm and The Swedish Wire.

The Stockholm Uppsala Life Science Hotlist, curated by Stockholm Business Region Development, has continued to gain members, with five more new, groundbreaking life science firms recently added.

All five newcomers are in digital health, an area where the Swedish capital stands out as a frontrunner.

One is Gnosco, a company which developed a mobile app and platform to relieve the bottleneck in the patient referral system between primary care practitioners and dermatology specialists.

Daniel Eliasson who founded Gnosco together with Johan Heilborn, said that being added to the list was recognition that their work was respected.

“Being accepted into this list, together with so many really successful companies, is of course confirmation that we are doing something right,” he said.

“This strengthens our position as a major part in the ecosystem, and gives us a good foundation for international expansion.”

Eliasson added that the firm is initiating the international rollout right now and is looking to find the right distribution, sales and financial partners.

A second newcomer to the hotlist is Pilloxa, which is developing a smart pill box that incorporates modern hard and software together with user friendly design. The goal is, simply, to “make taking medication easier so you can focus on living instead of being ill".

Co-founder Per Nilsson said it was an honor to be listed alongside other already successful startups in Stockholm. It was also a good way to reach out to customers, partners and investors, he added.

“There are many success stories based here and we hope to be the next one,” Nilsson said.

Another firm hoping to become another Stockholm success story is Optolexia, which is introducing a new screening method for dyslexia and other reading disorders.

“It is always nice to get a recognition and being selected to be part of an exclusive list like this,” said the company’s chief executive officer, Fredrik Wetterhall. “This creates attention both nationally and internationally. This is very positive and important for us since we launched our method in Sweden recently and will expand to other countries later this year.”

The company is also planning to adapt its method to other application areas.

“So far, without any marketing activities, we have got a lot of interest from other countries, mainly from US, Western Europe and Asia,” Wetterhall said.

The two other firms which were added to the list were Timesulin (which has developed a smart replacement cap for insulin pens) and Werlabs (providing health and blood tests).

Visit the Stockholm-Uppsala Life Science Hotlist.